Valuation: Arcoma AB

Market Cap 115M 11.83M 10.39M 9.7M 8.9M 16.67M 1.13B 17.08M 44.99M 561M 44.41M 43.44M 1.94B P/E 2024
12.7x
P/E 2025 20.9x
Enterprise Value 79.81M 8.21M 7.21M 6.73M 6.18M 11.56M 786M 11.85M 31.21M 389M 30.81M 30.14M 1.34B EV / Sales 2024
0.82x
EV / Sales 2025 0.53x
Free-Float
52.21%
Yield 2024 *
-
Yield 2025 -
1 day+0.25%
1 week-4.74%
Current month-9.87%
1 month-8.64%
3 months+8.06%
6 months+7.77%
Current year+9.54%
1 week 7.96
Extreme 7.96
8.4
1 month 7.02
Extreme 7.02
8.96
Current year 6.16
Extreme 6.16
10.05
1 year 6.16
Extreme 6.16
11
3 years 6.16
Extreme 6.16
18.3
5 years 6.16
Extreme 6.16
20.2
10 years 3.57
Extreme 3.57
26.3
Manager TitleAgeSince
Chief Executive Officer 45 2022-12-31
Director of Finance/CFO 42 2021-12-31
Chief Tech/Sci/R&D Officer - 2026-05-31
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Chairman 54 2016-12-31
Director/Board Member 59 2021-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%-4.74%-20.79%-10.17% 11.84M
+2.70%-0.47%-17.23%-21.68% 13.44B
+0.07%-8.14%+39.48%-12.31% 3.99B
-0.60%+0.19%+63.08%+114.72% 1.21B
+1.46%+2.25%-39.18%-59.33% 1.21B
+2.46%+3.43%-38.94%-47.00% 1.1B
+2.86%-2.96%-45.13% - 907M
-0.61%-1.93%+25.62%+80.83% 468M
+0.15%-4.05%+46.04% - 331M
-2.71%-10.44%-62.26%+196.20% 250M
Average +0.60%-0.99%-4.93%+30.16% 2.29B
Weighted average by Cap. +1.83%-0.43%-5.12%-10.98%

Financials

2024 2025
Net sales 157M 16.12M 14.17M 13.22M 12.14M 22.72M 1.54B 23.28M 61.32M 764M 60.53M 59.22M 2.64B 131M 13.45M 11.82M 11.03M 10.12M 18.95M 1.29B 19.42M 51.15M 637M 50.49M 49.4M 2.2B
Net income 11.18M 1.15M 1.01M 943K 865K 1.62M 110M 1.66M 4.37M 54.48M 4.32M 4.22M 188M 5.03M 517K 454K 424K 389K 729K 49.54M 747K 1.97M 24.51M 1.94M 1.9M 84.74M
Net Debt -13.32M -1.37M -1.2M -1.12M -1.03M -1.93M -131M -1.98M -5.21M -64.9M -5.14M -5.03M -224M -35.23M -3.62M -3.18M -2.97M -2.73M -5.1M -347M -5.23M -13.78M -172M -13.6M -13.3M -593M
Logo Arcoma AB
Arcoma AB is a Sweden-based medical technology company. It develops, produces and markets digital radiographic systems. Its products offer digital imaging technology combined with advanced mobile positioning system. The Company's product portfolio comprises: complete radiographic systems available as ceiling suspensions and floor mounted systems, as well as detectors; radiographic system components, such as overhead tube crane, cube, tilting wall stand and radiographic tables; and mobile imaging tables in two series, namely Precision and Elite. Its products are designed for hospitals, clinics, imaging centers and private practices, and available through three market channels: its own brand IMIX, private label distributors and original equipment manufacturers (OEM).
Employees
31
Date Price Change Volume
26-07-29 SEK 8.040 +0.25% 2,500
26-07-28 SEK 8.020 -3.14% 16,684
26-07-27 SEK 8.280 -0.72% 1,910
26-07-24 SEK 8.340 +3.99% 146
26-07-23 SEK 8.020 +0.75% 1,020

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ARCOMA Stock